Global Cardiac Pacemaker Market: Snapshot

By 2030, nearly 20% of the total U.S. population is expected to be made up of geriatrics, according to the U.S. Census Board. This is a huge growth in the number of elderly citizens in this country, and similar cases are being witnessed in most developed economies and a few developing ones as well. This rise in the geriatric population is expected to be the greatest driver for a lot of healthcare industry segments, including the market of cardiac pacemakers.

At the same time, the number of patients with heart complications is increasing significantly due to inculcation of modern lifestyles that can lead to obesity and high stress. Both factors are primarily responsible for the increasing demand for cardiac pacemakers among those younger than 65 years.

However, manufacturers of cardiac pacemakers also have to face problems such as the complex and time consuming approval procedure for sales of cardiac pacemakers due to their high risk nature of use. Additionally, players also have to significantly reduce their profit margins due to the implementation of policies such as the Affordable Healthcare Act in the U.S.

As a result of the given factors, the global revenue generated from cardiac pacemakers is expected to reach US$12.8 bn by the end of 2023, according to Transparency Market Research. In terms of volume, the total number of cardiac pacemakers consumed globally will cross 2.4 mn units.

Asia Pacific Shows High Growth Scope in Cardiac Pacemaker Demand

Based on the current trends in cardiac pacemaker supply and demand chains, Asia Pacific is expected to show the fastest growth rate, ending up with a share in volume of 20.3% by the end of 2023. The key factors responsible for the growth in cardiac pacemaker sales in this region include the growth in awareness of modern pacemakers and the increasing number of heart disease patients across the region.

Europe, however, is expected to retain its leading position for the number of cardiac pacemakers consumed. This region is expected to hold a volume share of 51.1% in 2023 due to a high percentage of the elderly and other heart disease patients. In terms of revenue, North America leads the global market for cardiac pacemakers.

Implantable Pacemakers Most Preferred Type Globally

Almost all of the cardiac pacemakers used in the world today are implantable as there are very few cases where external cardiac pacemakers would be required. Most patients with heart problems require implantable pacemakers. This segment is also expected to show the fastest growth rate for the coming few years due to a high global demand for advanced implantable cardiac pacemakers. The total revenue generated through implantable cardiac pacemakers is expected to reach US$12.5 bn by the end of 2023.

Most of the heart problem indicators point to the need for a permanent pacemaker. These include a complete atrio-ventricular blockage, symptomatic sinus bradycardia, and sick sinus syndrome. Sick sinus syndrome is additionally the most common illness faced by European patients in need of cardiac pacemakers.

The key companies in the cardiac pacemakers market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and Sorin. A very small share of the cardiac pacemakers market is taken up by regional players, as the above leader constitute most of the global supply currently.

Global Cardiac Pacemaker Market: Overview

The global market for cardiac pacemaker is a consolidated one wherein the top three players, namely St. Jude Medical, Medtronic, and Boston Scientific account for a large chunk of the market vis-à-vis sales and revenue. Some of their winning strategies have been new product development, expanding geographical outreach through astute deal-making and distribution channels, and sagacious pricing. The overall revenue in the global market for cardiac pacemakers is predicted to be worth US$12.8 bn by the end of 2023. Based on volume, the market is slated to have over 2.4 mn units by the end of 2023.

The report by Transparency Market Research, presents a detailed overview of the market by segmenting it based on product type, technology, and regions. Depending upon the product type, most of the cardiac pacemakers used these days are implantable. This is because cases in which external cardiac pacemakers are required are rare. Going forward too, they are expected to witness strong demand due to more advanced ones being unveiled in the market. The overall revenue generated through implantable cardiac pacemakers is expected to reach US$12.5 bn by 2023 end. Depending upon the underpinning technologies, the global market for cardiac pacemaker can be segmented into single chamber, dual pacemaker, and bi-ventricular. Among them, the dual chamber technology used is predicted to outshine all other segments in terms of growth.

Global Cardiac Pacemaker Market: Trends and Opportunities

According to the World Health Organization (WHO), cardio vascular diseases (CVDs) claimed almost 17.5 million lives in 2012. The WHO also pegs it as the number one cause of death worldwide. Globally, this has been the single-most important driver of demand for the artificial heart rate management devices such as cardiac pacemakers. Another factor filliping the demand is the burgeoning geriatric population worldwide and the changing lifestyle and eating habits that has led to the rising prevalence of high stress and obesity which often cause heart ailments. Further, proper reimbursement schemes for implantation of pacemaker, especially in developed countries of the world, has also upped demand for it.

A factor restraining the global market for cardiac pacemakers is the complicated and time consuming approval procedure for their sales on account of the high risk associated with their use. For example, the U.S. FDA labels cardiac pacemakers as Class III high-risk medical devices, thereby requiring all cardiac pacemakers be tested for safety thoroughly to be approved. Another deterrent is the implementation of policies such as the Affordable Healthcare Act in the U.S. that has brought down margins of major players.

Global Cardiac Pacemaker Market: Regional Outlook

Regionally, the global market for cardiac pacemakers can be segmented into Asia Pacific, North America, Europe, and the Rest of the World (RoW). Among them, North America is the market leader in terms of revenue because of the alarming instances of CVDs and robust healthcare infrastructure in the region. Going forward too, the market will lead on the back of a rising geriatric population. Europe in another major market for cardiac pacemakers due to a large pool of elderly population and rising instances of heart diseases. When it comes to growth rate, however, Asia Pacific is forecasted to outshine all other regions because of the rise in awareness about modern pacemakers and the burgeoning heart disease patients across the region.

Companies Mentioned in Report

The prominent names operating in the global cardiac pacemaker industry that have been profiled in the report include Boston Scientific, Medtronic, St. Jude Medical, Sorin, and Biotronik.

Global Cardiac Pacemaker Market is segmented as:

Global Cardiac Pacemakers Market, by Product Type

  • Implantable Cardiac Pacemaker
  • External Cardiac Pacemaker

Global Implantable Cardiac Pacemakers Market, by Technology

  • Dual-Pacemaker
  • Single-Chamber
  • Bi-Ventricular

Global Cardiac Pacemaker Market, by Geography

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments